Contracts › 75N98026P01258
75N98026P01258: The National Institute of Diabetes and Digestive and Kidney Diseases Conducts and Supports Biomedical Research to Improve the Understanding, Prevention, and Treatment of Diseases Affecting Human Health.
Awarded to Creagen Inc by National Institutes of Health (NIH).
$56Kobligated
$56Kpotential value
09 August 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N98026P01258 |
|---|---|
| Awardee | Creagen Inc |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH OLAO |
| NAICS | 325414 Biological Product (Except Diagnostic) Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | MA |
| Offers received | 1 |
| Period of performance | 10 August 2026 to 09 August 2027 |
| Potential end | 09 August 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325414 contracts · All expiring contracts · USASpending record